Relationship between leptin and C-reactive protein in young Finnish adults.

CONTEXT Leptin and C-reactive protein (CRP) concentrations are increased in inflammation, and both have been linked to increased risk for cardiovascular diseases. OBJECTIVE The objective of the study was to explore in a population-based sample whether the relation between leptin and CRP is independent of obesity level and whether genetic causes of CRP elevation contribute to leptin levels. DESIGN This was a population-based study including 1862 young adults (971 women; 891 men) aged 24-39 yr. SETTING The study was conducted at five centers in Finland. MAIN OUTCOME MEASURES Associations between leptin and CRP adjusted for obesity indices, risk factors, genetic variables, and lifestyle variables were measured. RESULTS Women had 3.0-fold higher median concentrations of leptin (12.5 vs. 4.1 ng/ml) and 1.3-fold higher median concentrations of CRP (0.75 vs. 0.56 mg/liter) than men (P < 0.0001 in both comparisons). In univariate analyses, CRP and leptin were significantly intercorrelated (r = 0.47, P < 0.0001 for women; r = 0.46, P < 0.0001 for men). In multiple regression analysis including age, body mass index, waist circumference, insulin, lipids, systolic and diastolic blood pressures, smoking status, and use of oral contraceptives in women, leptin was the main determinant of CRP in men (P < 0.0001) and the second most important determinant in women (P < 0.0001). A Mendelian randomization test based on genetic variants in the CRP gene (five single nucleotide polymorphisms) provided no support for CRP as a causal agent for leptin. CONCLUSIONS Leptin, obesity, and oral contraceptive use in women were the main factors related to CRP. The relation between leptin and CRP was independent of obesity and cardiovascular risk factors.

[1]  F. Hu,et al.  Circulating leptin levels are not associated with cardiovascular morbidity and mortality in women with diabetes: a prospective cohort study , 2007, Diabetologia.

[2]  C. Mantzoros,et al.  Genetic variability at the leptin receptor (LEPR) locus is a determinant of plasma fibrinogen and C-reactive protein levels. , 2007, Atherosclerosis.

[3]  A. Go,et al.  Plasma leptin levels and coronary artery calcification in older adults. , 2007, The Journal of clinical endocrinology and metabolism.

[4]  O. Raitakari,et al.  Assessment of inflammatory markers and endothelial function , 2006, Current opinion in clinical nutrition and metabolic care.

[5]  H. Cai,et al.  Induction of leptin resistance through direct interaction of C-reactive protein with leptin , 2006, Nature Network Boston.

[6]  G. Frühbeck,et al.  Intracellular signalling pathways activated by leptin. , 2006, The Biochemical journal.

[7]  J. Viikari,et al.  Distribution and determinants of serum high‐sensitive C‐reactive protein in a population of young adults. The Cardiovascular Risk in Young Finns Study , 2005, Journal of internal medicine.

[8]  S. Bandinelli,et al.  Relation of plasma leptin to C-reactive protein in older adults (from the Invecchiare nel Chianti study). , 2005, American Journal of Cardiology.

[9]  J. Chan,et al.  Role of leptin in energy-deprivation states: normal human physiology and clinical implications for hypothalamic amenorrhoea and anorexia nervosa , 2005, The Lancet.

[10]  C. Carlson,et al.  Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. , 2005, American journal of human genetics.

[11]  S. Ebrahim,et al.  What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? , 2005, BMJ : British Medical Journal.

[12]  J. Chan,et al.  Recombinant methionyl human leptin administration activates signal transducer and activator of transcription 3 signaling in peripheral blood mononuclear cells in vivo and regulates soluble tumor necrosis factor-alpha receptor levels in humans with relative leptin deficiency. , 2005, The Journal of clinical endocrinology and metabolism.

[13]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[14]  A. Localio,et al.  Plasma leptin levels are associated with coronary atherosclerosis in type 2 diabetes. , 2004, The Journal of clinical endocrinology and metabolism.

[15]  R. Poulton,et al.  Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults , 2004, International Journal of Obesity.

[16]  J. Tavernier,et al.  Leptin: linking adipocyte metabolism with cardiovascular and autoimmune diseases. , 2004, Progress in lipid research.

[17]  A. Gotto,et al.  Inflammation in Atherosclerosis and Implications for Therapy , 2004, Circulation.

[18]  V. Somers,et al.  Independent Association Between Plasma Leptin and C-Reactive Protein in Healthy Humans , 2004, Circulation.

[19]  J. Viikari,et al.  The 21‐year follow‐up of the Cardiovascular Risk in Young Finns Study: risk factor levels, secular trends and east–west difference , 2004, Journal of internal medicine.

[20]  M. Westerterp-Plantenga,et al.  Leptin and the proinflammatory state associated with human obesity. , 2004, The Journal of clinical endocrinology and metabolism.

[21]  T. Laitinen,et al.  Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study. , 2003, JAMA.

[22]  G. Yoshino,et al.  C-reactive protein in young, apparently healthy men: associations with serum leptin, QTc interval, and high-density lipoprotein-cholesterol. , 2003, Metabolism: clinical and experimental.

[23]  S. Phinney,et al.  Oral contraceptive use and increased plasma concentration of C-reactive protein. , 2003, Life sciences.

[24]  Mark B Pepys,et al.  C-reactive protein: a critical update. , 2003, The Journal of clinical investigation.

[25]  N. Sattar,et al.  Plasma Leptin and the Risk of Cardiovascular Disease in the West of Scotland Coronary Prevention Study (WOSCOPS) , 2001, Circulation.

[26]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[27]  R. Tracy,et al.  The effects of hormone replacement therapy and raloxifene on C-reactive protein and homocysteine in healthy postmenopausal women: a randomized, controlled trial. , 2000, The Journal of clinical endocrinology and metabolism.

[28]  V. Sánchez-Margalet,et al.  Human leptin stimulates proliferation and activation of human circulating monocytes. , 1999, Cellular immunology.

[29]  D. Jessop.  Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. , 1999, The Journal of endocrinology.

[30]  D. Jessop.  Central non-glucocorticoid inhibitors of the hypothalamo–pituitary–adrenal axis , 1999 .

[31]  R. Huupponen,et al.  Inverse correlation between serum testosterone and leptin in men. , 1998, The Journal of clinical endocrinology and metabolism.

[32]  Steven L. Cohen,et al.  Weight-reducing effects of the plasma protein encoded by the obese gene. , 1995, Science.

[33]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1995, Nature.

[34]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[35]  P. Heinrich,et al.  Acute‐phase response of human hepatocytes: Regulation of acute‐phase protein synthesis by interleukin‐6 , 1990, Hepatology.

[36]  J. Viikari,et al.  Atherosclerosis precursors in Finnish children and adolescents. I. General description of the cross‐sectional study of 1980, and an account of the children's and families' state of health , 1985, Acta paediatrica Scandinavica. Supplement.

[37]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.